These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32270628)

  • 21. A physiologically-based pharmacokinetic/pharmacodynamic modeling approach for drug-drug-gene interaction evaluation of S-warfarin with fluconazole.
    Geng K; Shen C; Wang X; Wang X; Shao W; Wang W; Chen T; Sun H; Xie H
    CPT Pharmacometrics Syst Pharmacol; 2024 May; 13(5):853-869. PubMed ID: 38487942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An expanded pharmacogenomics warfarin dosing table with utility in generalised dosing guidance.
    Shahabi P; Scheinfeldt LB; Lynch DE; Schmidlen TJ; Perreault S; Keller MA; Kasper R; Wawak L; Jarvis JP; Gerry NP; Gordon ES; Christman MF; Dubé MP; Gharani N
    Thromb Haemost; 2016 Aug; 116(2):337-48. PubMed ID: 27121899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of CYP2C9-VKORC1 interaction on warfarin stable dosage and its predictive algorithm.
    Li X; Liu R; Yan H; Tang J; Yin JY; Mao XY; Yang F; Luo ZY; Tan SL; He H; Chen XP; Liu ZQ; Li Z; Zhou HH; Zhang W
    J Clin Pharmacol; 2015 Mar; 55(3):251-7. PubMed ID: 25187307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects.
    Hawcutt DB; Ghani AA; Sutton L; Jorgensen A; Zhang E; Murray M; Michael H; Peart I; Smyth RL; Pirmohamed M
    Pharmacogenomics J; 2014 Dec; 14(6):542-8. PubMed ID: 25001883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population.
    Chumnumwat S; Yi K; Lucksiri A; Nosoongnoen W; Chindavijak B; Chulavatnatol S; Sarapakdi A; Nathisuwan S
    Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29243335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients.
    Ye C; Jin H; Zhang R; Sun Y; Wang Z; Sun W; Sun W; Peng Q; Liu R; Huang Y
    J Int Med Res; 2014 Feb; 42(1):67-76. PubMed ID: 24287930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450 2C9 gene polymorphism and warfarin maintenance dosage in pediatric patients: A systematic review and meta-analysis.
    Zhang J; Tian L; Huang J; Huang S; Chai T; Shen J
    Cardiovasc Ther; 2017 Feb; 35(1):26-32. PubMed ID: 27661060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Renal Impairment and Genetic Subtypes on Warfarin Control in Japanese Patients.
    Tanaka T; Ihara M; Fukuma K; Yamamoto H; Washida K; Kimura S; Kada A; Miyata S; Miyata T; Nagatsuka K
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VKORC1 and CYP2C9 genotype distribution in Asian countries.
    Gaikwad T; Ghosh K; Shetty S
    Thromb Res; 2014 Sep; 134(3):537-44. PubMed ID: 24908449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotyping of CYP2C9 and VKORC1 polymorphisms predicts south Indian patients with deep vein thrombosis as fast metabolizers of warfarin/acenocoumarin.
    Arunkumar G; Vishnuprabu D; Nupur B; Vidyasagaran T; Murugan AK; Munirajan AK
    Drug Discov Ther; 2017; 11(4):198-205. PubMed ID: 28867752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between genetic polymorphisms of CYP2C9 and VKORC1 and safety and efficacy of warfarin: Results of a 5 years audit.
    Biswas M; Bendkhale SR; Deshpande SP; Thaker SJ; Kulkarni DV; Bhatia SJ; Rajadhyaksha AG; Gogtay NJ; Thatte UM
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S13-S19. PubMed ID: 30595245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.
    Farzamikia N; Sakhinia E; Afrasiabirad A
    Lab Med; 2017 Dec; 49(1):25-34. PubMed ID: 29182754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variations of phenprocoumon metabolism in patients with ventricular assist devices.
    Brehm K; Krumnau O; Heilmann C; Beyersdorf F
    Eur J Cardiothorac Surg; 2016 Aug; 50(2):275-80. PubMed ID: 26984978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of VKORC1 and CYP2C9 polymorphisms on warfarin dose requirement in Bangladeshi population.
    Chowdhury ZS; Shahjin F; Akter F; Ahmed M; Islam MS; Bin Sayeed MS; Islam R; Hasnat A
    Pak J Pharm Sci; 2017 Mar; 30(2):341-346. PubMed ID: 28649054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy].
    Liu Y; Zhong SL; Tan HH; Yang M; Fei HW; Yu XY; Lin SG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):929-35. PubMed ID: 22321278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of warfarin dose requirements in South African patients attending an anticoagulation clinic.
    Schapkaitz E; Sithole J
    J Vasc Nurs; 2017 Mar; 35(1):27-30. PubMed ID: 28224948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.
    Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY
    Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of CYP2C9 polymorphism on the fall in International Normalized Ratio in patients interrupting warfarin therapy before elective surgery.
    Abohelaika S; Wynne H; Avery P; Kamali F
    J Thromb Haemost; 2015 Aug; 13(8):1436-40. PubMed ID: 26010205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to use warfarin assays in patient management: analysis of 437 warfarin measurements in a clinical setting.
    Lee K; Woo HI; Bang OY; On YK; Kim JS; Lee SY
    Clin Pharmacokinet; 2015 May; 54(5):517-25. PubMed ID: 25466603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients.
    Miao L; Yang J; Huang C; Shen Z
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1135-41. PubMed ID: 17899045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.